bluebird bio Inc
(LTS:0HOH)
$
0.5004
0.0109 (2.23%)
Market Cap: 96.39 Mil
Enterprise Value: 342.75 Mil
PE Ratio: 0
PB Ratio: 1.82
GF Score: 29/100 bluebird bio Inc at Citi Biotech Conference Transcript
Sep 04, 2019 / 12:00PM GMT
Release Date Price:
$99.72
Mohit Bansal
Deutsche Bank AG, Research Division - Research Associate
Good morning. Thank you very much all of you to -- for joining us today. My name is Mohit Bansal, I'm one of the biotech analysts here at Citi, and we are pleased to start the session with bluebird bio. And with us today, we have Chief bluebird, Nick Leschly; and David Davidson, CMO of the company. Thank you very much for joining us today.
Nick Leschly
bluebird bio, Inc. - President, CEO & Director
Thank you for having us.
David M. Davidson
bluebird bio, Inc. - Chief Medical Officer
My pleasure.
Questions & Answers
Mohit Bansal
Deutsche Bank AG, Research Division - Research Associate
So Nick, for the benefit of our audience who are on the webcast as well who are here, if you can briefly start with talking about what you're up to right now? And how you are thinking about what's the vision for the company and how you're thinking about the company in next 12 to 18 months?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot